Healthy London Partnership > Our work > Cancer > Cancer data > Patient experience survey

Patient experience survey

Results and analysis from the 2019 National Cancer Patient Experience Survey for London CCGs

National Cancer Patient Experience Survey analysis for London

The National Cancer Patient Experience Survey aims to improve a patient’s experience of their cancer care and to inform commissioners and service providers about the cancer patients’ experience.

The Transforming Cancer Services Team for London has published an analysis (in the form of an interactive dashboard) of the results every year from 2016 for each London CCG and STP and hospital prover as well as for each cancer alliance and the London region to help support commissioners in their work to improve cancer care for patients.

The dashboard enables commissioners, clinical leaders and the public to have an understanding of the cancer patient experience in their locality by reviewing the patient experience data alongside the qualitative analysis.

For the latest survey (2019) we have analysed the data to see if there are any statistical inequalities in regards to ethnicity, age, sexual orientation and deprivation

‘Patients with certain characteristics report less positive experiences in cancer care. In this dashboard we provide analysis of the National Cancer Patient Experience Survey 2018 and 2019 data, focussing on how the experience of ethnic minority patients, patients with minority sexual orientations (Gay, Lesbian, Bisexual and orientations other than Heterosexual), patients in the 20% most deprived population segment and people of different ages in London compares to the experience of patients outside of London.

Patient experience dashboards

National Cancer Patient Experience Survey 2015 – 2019

National Cancer Patient Experience Survey 2018 dashboard

National Cancer Patient Experience Survey 2017 dashboard.

National Cancer Patient Experience Survey timeseries 2015-2017.

National Cancer Patient Experience Survey 2016 dashboard.

« Back to Cancer data